Clinical Trials Directory

Trials / Sponsors / Sound Pharmaceuticals, Incorporated

Sound Pharmaceuticals, Incorporated

Industry · 12 registered clinical trials — 2 currently recruiting.

StatusTrialPhaseStarted
RecruitingSPI-1005 for the Treatment of Meniere's Disease (Open Label)
Meniere's Disease, Ménière's Disease
Phase 32025-10-29
RecruitingSPI-1005 in Adults Receiving Cochlear Implant
Hearing Loss, Cochlear Trauma
Phase 22025-08-01
CompletedSPI-1005 for the Treatment of Meniere's Disease
Meniere Disease, Ménière
Phase 32022-08-02
UnknownSPI-1005 Treatment in Moderate COVID-19 Patients
Covid19, Corona Virus Infection, Coronavirus
Phase 22021-10-12
UnknownSPI-1005 Treatment in Severe COVID-19 Patients
Covid19, Coronavirus, Coronavirus Infection
Phase 22021-08-27
UnknownA Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss
Noise Induced Hearing Loss
Phase 22018-11-01
UnknownSPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss
Lung Cancer, Head and Neck Cancer, Hearing Loss
Phase 22018-01-15
CompletedSPI-1005 for the Treatment of Patients With Meniere's Disease
Meniere's Disease
Phase 22017-09-28
CompletedSPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity
Ototoxicity
Phase 22017-07-21
CompletedStudy to Evaluate SPI-1005 in Adults With Meniere's Disease
Meniere's Disease
Phase 1 / Phase 22015-12-01
CompletedOtoprotection With SPI-1005 for Prevention of Temporary Auditory Threshold Shift
Temporary Auditory Threshold Shift
Phase 22011-09-01
CompletedStudy to Evaluate the Safety and Pharmacokinetics of SPI-1005
Hearing Loss, Cancer
Phase 12006-05-01